While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...

The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...

CiteAb, a Sci-Tech company specialising in data collection, announces the launch of CiteAb Unlimited for pharmaceutical and biotechnology companies. This service provides private access to a database ...

If you have concerns about your use of Depo-Provera, we would like to hear from you. Please complete the contact form on this page, send us an email at info@classlawdc.com, or give us a call at (202) ...

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with ...